295
Views
4
CrossRef citations to date
0
Altmetric
Harm Reduction

A Primary Care/Multidisciplinary Harm Reduction Clinic Including Opiate Bridging

, , &
Pages 1628-1639 | Published online: 03 Jul 2009

References

  • Bell J., Dru A., Fischer B., Levit S., Sarfraz M. A. Substitution therapy for heroin addiction. Substance Use and Misuse 2002; 37: 1149–1178
  • Broome K. M., Joe G. W., Simpson D. D. HIV risk reduction in outpatient drug abuse treatment: Individual and geographic differences. AIDS Education and Prevention 1999; 11: 293–306
  • Cronquist A., Edwards V., Galea S., Latka M., Vlahov D. Health care utilization among young adult injection drug users in Harlem, New York. Journal of Substance Abuse 2001; 13: 17–27
  • Donovan D. M., Rosengren D. B., Downey L., Cox G. B., Sloan K. L. Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction 2001; 96: 1149–1160
  • Eder H., Jagsch R., Kraigher D., Primorac A., Ebner N., Fischer G. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 2005; 100: 1101–1109
  • Festinger D. S., Lamb R. J., Kountz M. R., Kirby K. C., Marlowe D. Pretreatment dropout as a function of treatment delay and client variables. Addictive Behaviours 1995; 20: 111–115
  • Friedmann P. D., Hendrickson J. C., Gerstein D. R., Zhang Z., Stein M. D. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care?. Medical Care 2006; 44: 8–15
  • Friedmann P. D., Lemon S. C., Stein M. D., D'Aunno T. A. Accessibility of addiction treatment: Results from a national survey of outpatient abuse treatment organizations. Health Services Research 2003; 38: 887–903
  • Gerstein D. R., Lewin L. S. Treating drug problems. New England Journal of Medicine 1990; 323: 844–848
  • Gunn N., White C., Srinivasan R. Primary care as harm reduction for injection drug users. Journal of the American Medical Association 1998; 280: 1191–1195
  • Habbard R. L., Craddock S. G., Flynn P. M., Anderson J., Etheridge R. M. Overview of one-year follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviours 1997; 11: 261–278
  • Hser Y. I., Magloine M., Polinsky M. L., Anglin M. D. Predicting drug treatment entry among treatment-seeking individuals. Journal of Substance Abuse Treatment 1998; 15: 213–220
  • Krantz M. J., Mehler P. S. Treating opioid dependence. Growing implications for primary care. Archives of Internal Medicine 2004; 164: 277–288
  • Krook A. L., Brors O., Dahlberg K., Grouff K., Magnus P., Roysamb E., et al. A placebo controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway. Addiction 2002; 97: 533–542
  • Leshner A. I. Science-based views of drug addiction and its treatment. Journal of the American Medical Association 1999; 282: 1314–1316
  • McLellan A. T., Lewis D. C., O'Brien C. P., Kleber H. D. Drug dependence, a chronic medical illness: Implications for treatment, insurance and outcomes evaluations. Journal of the American Medical Association 2000; 284: 1689–1695
  • Metzger D. S., Navaline H., Woody G. E. Drug abuse treatment as AIDS prevention. Public Health Reports 1998; 113(1 Suppl)97–106
  • Metzger D. S., Woody G. E., McLellan A. T., O'Brein C. P., Druley P., Navaline H., et al. Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of-treatment: An eighteen-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 1993; 6: 1049–1056
  • Mitchell T. B., White J. M., Somogyi A. A., Bochner F. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction 2004; 99: 940–945
  • O'Connor P. G., Schottenfeld R. S. Patients with alcohol problems. New England Journal of Medicine 1998; 338: 592–602
  • Picollo P., Borg L., Lin A., Melia D., Ho A., Kreek M. J. Hepatitis C virus and human immunodeficiency virus–1 co-infection in former heroin addicts in methadone maintenance treatment. Journal of Addictive Diseases 2002; 21: 55–66
  • Rosenbaum M. The demedicalization of methadone maintenance. Journal of Psychoactive Drugs 1995; 27: 45–49
  • Saitz R., Horton N. J., Larson M. J., Winter M., Samet J. H. Primary medical care and reductions in addiction severity: a prospective cohort study. Addiction 2005; 100: 70–78
  • Schwartz R. P., Highfield D. A., Jaffe J. H., Brady J. V., Butler C. B., Rouse C. O. A randomized controlled trial of interim methadone maintenance. Archives of General Psychiatry 2006; 63: 102–109
  • Simpson D. D., Joe G. W., Rowan-Szal G. A. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence 1997; 47: 227–235
  • Sindelar J. L., Fiellin D. A. Innovations in treatment for drug abuse: solutions to a public health problem. Annual Review of Public Health 2001; 22: 249–272
  • Stark M. J., Campbell B. K., Brinkerhoff C. V. ‘Hello, May we help you?’ A study of attrition prevention at the time of the first phone contact with substance-abusing clients. The American Journal of Drug and Alcohol Abuse 1990; 16: 67–76
  • Stein M. D. Medical consequences of substance abuse. The Psychiatric Clinics of North America 1999; 22: 351–370
  • Van de Brink W., Haasen C. Evidence-based treatment of opioid-dependent patients. Canadian Journal of Psychiatry 2006; 51: 635–646
  • Wood E., Li K., Palepu A., Marsh D. C., Schechter M. T., Hogg R. S., et al. Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. Substance Use and Misuse 2005; 40: 1153–1167

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.